Burden of human papillomavirus-related cervical disease in the extended Middle East and North Africa - A comprehensive literature review

Journal of Lower Genital Tract Disease

Volumn 16, Issue 2, 2012, Pages 106-120

  Seoud, Muhieddine ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

cervical; cervix; Extended Middle East and North Africa; human papillomavirus

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER SCREENING; CONDYLOMA ACUMINATUM; FEMALE GENITAL TRACT CYTOLOGY; HEALTH BELIEF; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 59; MARRIAGE; MIDDLE EAST; NORTH AFRICA; PREVALENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SOCIAL BEHAVIOR; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

AFRICA, NORTHERN; BEHAVIOR THERAPY; CONDYLOMATA ACUMINATA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE EAST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS;

EID: 84858112030     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31823a0108     Document Type: Article

References (142)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10. (Pubitemid 38258322)
2. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(suppl 1):S1-15.
3. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202:1789-99.
4. World Health Organization. AIDS and Sexually Transmitted Diseases. Available at: http://www.emro.who.int/asd/hivsituation-regionalprofile.htm#S2. Accessed September 2011.
5. Assaad R, Roudi-Fahimi F. -outh in the Middle East and North Africa: Demographic Opportunity or Challenge? Available at: http://www.prb.org/pdf07/- outhinMENA.pdf. Accessed September 2011.
6. Aras S, Semin S, Gunay T, Orcin E, Ozan S. Sexual attitudes and risk-taking behaviors of high school students in Turkey. J Sch Health 2007;77:359-66; quiz 79-81.
7. Telegraph. Rise of Pre-marital Sex in Iran. Available at: http://www.telegraph.co.uk/news/worldnews/middleeast/iran/4001421/ Rise-of-pre-marital-sex-in-Iran.html. Accessed September 2011.
8. Aras S,OrcinE,Ozan S, Semin S. Sexual behaviours and contraception among university students in Turkey. J Biosoc Sci 2007;39:121-35. (Pubitemid 46648330)
9. UNICEF and World Health Organization. Immunization Summary. Available at: www.childinfo.org/files/Immunization-Summary-2008-r6.pdf. Accessed September 2011.
10. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008;43:S5-25, S25.e1-41.
11. Mitrani-Rosenbaum S, Gal D, Friedman M, Kitron N, Tsvieli R, Mordel N, et al. Papillomaviruses in lesions of the lower genital tract in Israeli patients. Eur J Cancer Clin Oncol 1988;24:725-31. (Pubitemid 18095580)
12. Onan MA, Taskiran C, Bozdayi G, Biri A, Erdem O, Acar A, et al. Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population. Eur J Gynaecol Oncol 2005;26:632-5. (Pubitemid 43028058)
13. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. November 15, 2010. World. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/XWX.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
14. US Department of State. Saudi Arabia Country Specific Information. Available at: http://travel.state.gov/travel/cis-pa-tw/cis/cis-1012.html. Accessed September 2011.
15. Al-Muammar T, Al-Ahdal MN, Hassan A, Kessie G, Dela Cruz DM, Mohamed GE. Human papilloma virus-16/18 cervical infection among women attending a family medical clinic in Riyadh. Ann Saudi Med 2007;27:1-5. (Pubitemid 46579111)
16. Hajjaj AA, Senok AC, Al-Mahmeed AE, Issa AA, Arzese AR, Botta GA. Human papillomavirus infection among women attending health facilities in the Kingdom of Bahrain. Saudi Med J 2006;27:487-91.
17. UnitedNations.WorldMarriage Data 2008. Available at: http://www.un.org/ esa/population/publications/WMD2008/Main.html. Accessed September 2011.
18. Crochard A, Luyts D, di Nicola S, Goncalves MA. Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs. Gynecol Oncol 2009;115:S7-14.
19. Hassen E, Chaieb A, Letaief M, Khairi H, Zakhama A, Remadi S, et al. Cervical human papillomavirus infection in Tunisian women. Infection 2003;31:143-8. (Pubitemid 36737034)
20. Algeria 1992: results from the PAPCHILD survey. Stud Fam Plann 1994;25:191-5.
21. Biri A, Korucuoglu U, Ilhan M, Bingol B, Yilmaz E, Biri H. Turkish women's level of knowledge on and attitude toward sexual health. Maturitas 2007;58:236-40. (Pubitemid 350086834)
22. Ozcelik B, Serin IS, Gokahmetoglu S, Basbug M, Erez R. Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol 2003;24:157-9. (Pubitemid 36389360)
23. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behaviour in context: a global perspective. Lancet 2006;368:1706-28. (Pubitemid 46055217)
24. Faisel A, Cleland J. Migrant men: a priority for HIV control in Pakistan? Sex Transm Infect 2006;82:307-10. (Pubitemid 44229445)
25. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Algeria. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/DZA.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
26. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Morocco. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/MAR.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
27. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Bahrain. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/BHR.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
28. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Iran. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/IRN.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
29. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Saudi Arabia. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/SAU.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
30. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Afghanistan. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/AFG.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
31. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Egypt. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/EG-.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
32. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Iraq. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/IRQ.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
33. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Jordan. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/JOR.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
34. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Kuwait. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/KWT.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
35. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Lebanon. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/LBN.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
36. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Libya. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ ico/country-pdf/LB-.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
37. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Oman. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/OMN.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
38. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Pakistan. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/PAK.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
39. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Syria. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/S-R.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
40. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Sudan. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/SDN.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
41. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Qatar. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/QAT.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
42. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Tunisia. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ ico/country-pdf/TUN.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
43. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. Turkey. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/TUR.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
44. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. United Arab Emirates. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/ARE.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
45. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15, 2010. -emen. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ ico/country-pdf/-EM.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
46. World Health Organization. Human Papillomavirus and Related Cancers. Summary Report Update. September 15,2010. Israel. Available at: http://apps.who.int/hpvcentre/statistics/dynamic/ico/country-pdf/ISR.pdf?CFID= 4246060&CFTOKEN=89208192. Accessed September 2011.
47. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11: 1048-56.
48. Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006;24(suppl 3):S52-61. (Pubitemid 44293018)
49. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163: 503-8.
50. Murillo R, Molano M, Martinez G, Mejia JC, Gamboa O.HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country. Infect Dis Obstet Gynecol 2009;2009:653598.
51. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008;26(suppl 10):K1-16.
52. Finer LB. Trends in premarital sex in the United States, 1954-2003. Public Health Rep 2007;122:73-8.
53. Friedman HL. Changing patterns of adolescent sexual behavior: consequences for health and development. J Adolesc Health 1992;13:345-50.
54. Tabutin D, Schoumaker B. The demography of the Arab world and the Middle East from the 1950s to the 2000s. Population 2005;60:505-616.
55. Planned Parenthood Federation of America, Inc. Outercourse. Available at: http://www.plannedparenthood.org/health-topics/birth-control/outercourse-4371. htm. Accessed September 2011.
56. Cobb JC. Outercourse as a safe and sensible alternative to contraceptives. Am J Public Health 1997;87:1380-1.
57. CDC. Sexually Transmitted Diseases Surveillance, 2007. Available at: http://www.cdc.gov/std/stats07/figures/45.htm. Accessed September 2011.
58. Hammouda D, Munoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005;113:483-9. (Pubitemid 40038719)
59. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
60. Ahmed MI, Salahy EE, Fayed ST, El-Hefnawy NG, Khalifa A. Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha. Clin Biochem 2001;34:491-8. (Pubitemid 33001319)
61. Chaouki N, Bosch FX, Munoz N, Meijer CJ, El Gueddari B, El Ghazi A, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-54. (Pubitemid 28094099)
62. Amrani M, Lalaoui K, El Mzibri M, Lazo P, Belabbas MA. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Clin Virol 2003;27:286-95. (Pubitemid 36870905)
63. World Health Organization. WHO/ICO Information Centre on Human Papilloma Virus (HPV) and Cervical Cancer. Available at: http://www.who.int/hpvcentre/en/. Accessed September 2011.
64. Khair MM, Mzibri ME, Mhand RA, Benider A, Benchekroun N, Fahime EM, et al. Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women. J Med Virol 2009;81:678-84.
65. Menczer J, Fintsi Y, Arbel-Alon S, Tell L, Friedman E, Jackman A, et al. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Eur J Gynaecol Oncol 2000;21:30-4. (Pubitemid 30088084)
66. Sughayer MA, Abdelhadi M, Abdeen G, Otay L, Dayeh T. Human papillomavirus genotypes in invasive cervical cancer in Jordan. Int J Gynaecol Obstet 2010;108:74-5.
67. Seoud M, Alemany L, Bosch F, de Sanjosé S, Khalil A, Muñoz N, et al. Prevalence and types of human papillomavirus in cervical cancer: comparison between local and international data-lessons to learn. Gynecol Oncol 2010;116:S39.
68. Hamkar R, Azad TM, Mahmoodi M, Seyedirashti S, Severini A, Nategh R. Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran. East Mediterr Health J 2002;8:805-11. (Pubitemid 40326289)
69. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A. The prevalence of human papillomavirus in cervical cancer in Iran. Asian Pac J Cancer Prev 2002;3:69-72.
70. Maleknejad P, Rakhshan M, Kazemi B, Farokh F, Shahsavan S. Detection of human papillomavirus types 16 and 18 in pathologic samples from patients with cervical cancer by PCR and RFLP methods. DARU 2006;14:78-81. (Pubitemid 43971920)
71. Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP, et al. High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res 2003; 9:121-5. (Pubitemid 36958634)
72. Anwar K, Inuzuka M, Shiraishi T, Nakakuki K. Detection of HPV DNA in neoplastic and non-neoplastic cervical specimens from Pakistan and Japan by non-isotopic in situ hybridization. Int J Cancer 1991;47:675-80.
73. Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A, et al. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis 2007;11:313-7. (Pubitemid 46990965)
74. Raza SA, Franceschi S, Pallardy S, Malik FR, Avan BI, Zafar A, et al. Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer 2010;102:1657-60.
75. Usubutun A, Alemany L, Kucukali T, Ayhan A, -uce K, de Sanjose S, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009;28:541-8.
76. Nabi S, Trimeche M, Ziadi S, Baccouche D, Amara K, Mestiri S, et al. Prevalence of high risk oncogen HPV by in situ hybridization and by PCR in condyloma acuminata in the region of the Tunisian Center [in French]. Tunis Med 2006; 84:170-6.
77. Kharfi M, Slim A, Mokhtar I, Arrouji Z, Ben Halima M, Zghal M, et al. Evaluation of the frequency of oncogenic HPV in venereal condyloma. Prospective study of 24 patients [in French]. Tunis Med 2000;78:508-11.
78. el-All HS, Refaat A, Dandash K. Prevalence of cervical neoplastic lesions and human papilloma virus infection in Egypt: National Cervical Cancer Screening Project. Infect Agent Cancer 2007;2:12.
79. Lalaoui K, El Mzibri M, Amrani M, Belabbas MA, Lazo PA. Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control. Clin Microbiol Infect 2003;9:144-8. (Pubitemid 36527060)
80. Bar-Am A, Niv J, Jaffo A, Peyser RM. Prevalence of human papillomavirus infection and HPV DNA among male partners of Israeli women with genital premalignant and human papillomavirus lesions. Isr J Med Sci 1995;31:349-52.
81. Grisaru D, Avidor B, Niv J, Marmor S, Almog B, Leibowitz C, et al. Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination. J Clin Microbiol 2008;46:1602-5. (Pubitemid 351657201)
82. Guney AI, Ince U, Kullu S, Pekin S, Cirakoglu B. Detection and typing of human papillomavirus in cervical specimens of Turkish women. Eur J Gynaecol Oncol 1997;18: 546-50. (Pubitemid 27519433)
83. Ergunay K, Misirlioglu M, Pinar F, Tuncer ZS, Tuncer S, Ustacelebi S. Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus [in Turkish]. Mikrobiyol Bul 2007;41:219-26.
84. Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009;9:191.
85. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, et al. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev 2006;7: 529-32.
86. Hassen E, Remadi S, Chouchane L. Detection and molecular typing of human papillomaviruses: prevalence of cervical infection in the Tunisian central region [in French]. Tunis Med 1999;77:497-502.
87. De Marco F, Houissa-Kchouk F, Khelifa R, Marcante ML. High-risk HPV types in Tunisia. A pilot study reveals an unexpectedly high prevalence of types 58 and 82 and lack of HPV 18 among female prostitutes. J Med Virol 2006;78: 950-3. (Pubitemid 43856704)
88. Abdel Aziz MT, Abdel Aziz MZ, Atta HM, Shaker OG, Abdel Fattah MM, Mohsen GA, et al. Screening for human papillomavirus (HPV) in Egyptian women by the second-generation hybrid capture (HC II) test. Med Sci Monit 2006;12:MT43-9. (Pubitemid 44031648)
89. IsacsohnM, Dolberg L, Sabag SG, Mitrani-Rosenbaum S, Nubani N, Diamant-Z, et al. The inter-relationship of herpes virus, papilloma 16/18 virus infection and Pap smear pathology in Israeli women. Isr J Med Sci 1994;30:383-7. (Pubitemid 24209033)
90. Lubbad AM, Al-Hindi AI. Bacterial, viral and fungal genital tract infections in Palestinian pregnant women in Gaza, Palestine. West Afr J Med 2007;26:138-42. (Pubitemid 47499925)
91. Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 2002;23:429-32. (Pubitemid 35364673)
92. Safaei A, Khanlari M, Momtahen M, Monabati A, Robati M, Amooei S, et al. Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J Pathol Microbiol 2010;53:681-5.
93. Cirpan T, Guliyeva A, Onder G, Terek MC, Ozsaran A, Kabasakal Y, et al. Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjogren's syndrome. Eur J Gynaecol Oncol 2007;28: 302-6. (Pubitemid 47238000)
94. Ozturk S, Kaleli I, Kaleli B, Bir F. Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay [in Turkish]. Mikrobiyol Bul 2004;38:223-32.
95. Inal MM, Kose S, -ildirim -, Ozdemir -, Toz E, Ertopcu K, et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007;17:1266-70. (Pubitemid 350077363)
96. Aydin -, Atis A, Tutuman T, Goker N. Prevalence of human papilloma virus infection in pregnant Turkish women compared with non-pregnant women. Eur J Gynaecol Oncol 2010;31:72-4.
97. Gazzaz FB. Molecular testing of human papillomavirus in cervical specimens. Saudi Med J 2007;28:1810-8.
98. Al-Awadhi R, Chehadeh W, Kapila K. Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. J Med Virol 2011;83:453-60.
99. Sullam SA, Mahfouz AA, Dabbous NI, el-Barrawy M, el-Said MM. Reproductive tract infections among married women in Upper Egypt. East Mediterr Health J 2001;7: 139-46. (Pubitemid 33758533)
100. Ali F, Aziz AA, Helmy MF, Mobdy AA, Darwish M. Prevalence of certain sexually transmitted diseases in Egypt. J Egypt Public Health Assoc 1996;71:553-75.
101. Mostafa SR, Roshdy OH. Risk profiles for sexually transmitted diseases among patients attending the venereal disease clinic at Alexandria Main University Hospital. East Mediterr Health J 1999;5:740-54.
102. Bamberger ES, Siegler E, Makler-Shiran E, Patel MV, Steinberg JM, Gershtein R, et al. Chlamydia trachomatis infections in female soldiers, Israel. Emerg Infect Dis 2003;9: 1344-6. (Pubitemid 37210584)
103. Cwikel JG, Lazer T, Press F, Lazer S. Sexually transmissible infections among illegal female sex workers in Israel. Sex Health 2006;3:301-3.
104. Joffe H, Bamberger E, Nurkin S, Kedem E, Kra-Oz Z, Pollack S, et al. Sexually transmitted diseases among patients with human immunodeficiency virus in northern Israel. Isr Med Assoc J 2006;8:333-6. (Pubitemid 43805050)
105. Srugo I, Steinberg J, Madeb R, Gershtein R, Elias I, Tal J, et al. Agents of non-gonococcal urethritis in males attending an Israeli clinic for sexually transmitted diseases. Isr Med Assoc J 2003;5:24-7. (Pubitemid 36204046)
106. Mawajdeh SM, Al-Qutob R, Schmidt A. Measuring reproductive morbidity: a community-based approach, Jordan. Health Care Women Int 2003;24:635-49. (Pubitemid 37414660)
107. Awwad ZM, Al-Amarat AA, Shehabi AA. Prevalence of genital chlamydial infection in symptomatic and asymptomatic Jordanian patients. Int J Infect Dis 2003;7:206-9. (Pubitemid 37314366)
108. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi W-. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 2002; 43:277-81. (Pubitemid 34874769)
109. Finan RR, Musharrafieh U, Almawi WY. Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women. Clin Microbiol Infect 2006;12: 927-30. (Pubitemid 44151297)
110. Rehan N. Profile of men suffering from sexually transmitted infections in Pakistan. J PakMed Assoc 2006;56:S60-5.
111. Sami S, Baloch SN. Vaginitis and sexually transmitted infections in a hospital based study. J Pak Med Assoc 2005; 55:242-4. (Pubitemid 41323209)
112. Khanani R, Memon AR, Shaikh RB, Ali G, Shaikh M, Sandila T, et al. beta-Lactamase producing Neisseria gonorrhea strains in Karachi. J Pak Med Assoc 1994;44:70-1. (Pubitemid 24107371)
113. Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis 2007;11: 407-12. (Pubitemid 47239449)
114. Kafi SK, Mohamed AO, Musa HA. Prevalence of sexually transmitted diseases (STD) among women in a suburban Sudanese community. Ups J Med Sci 2000;105:249-53.
115. Taha OM, Ali MH, Omer EE, Ahmed MA, Abbaro SA. Study of STDs in patients attending venereal disease clinics in Khartoum, Sudan. Br J Vener Dis 1979;55:313-5. (Pubitemid 10188408)
116. Omer EE, Ali MH, Taha OM, Ahmed MA, Abbaro SA. Sexually transmitted diseases in Sudanese males. Trop Doct 1982;12:208-10. (Pubitemid 13215141)
117. Al-Mutairi N, Joshi A, Nour-Eldin O, Sharma AK, El-Adawy I, Rijhwani M. Clinical patterns of sexually transmitted diseases, associated sociodemographic characteristics, and sexual practices in the Farwaniya region of Kuwait. Int J Dermatol 2007;46:594-9. (Pubitemid 46909401)
118. Radouani F, Takourt B, Benomar H, Guerbaoui M, Bekkay M, Boutaleb Y, et al. Chlamydia infection and female low fertility in Morocco [in French]. Pathol Biol (Paris) 1997; 45:491-5. (Pubitemid 27306144)
119. Alami K, Ait Mbarek N, Akrim M, Bellaji B, Hansali A, Khattabi H, et al. Urethral discharge in Morocco: prevalence of microorganisms and susceptibility of gonococcos [in French]. East Mediterr Health J 2002;8:794-804. (Pubitemid 40326288)
120. Heikel J, Sekkat S, Bouqdir F, Rich H, Takourt B, Radouani F, et al. The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic. Eur J Epidemiol 1999;15:711-5. (Pubitemid 29493110)
121. Massoud M, Noweir A, Salah M, Saleh WA. Chlamydial infection in Riyadh, Saudi Arabia. J Egypt Public Health Assoc 1991;66:411-9.
122. Bashawri LA. Pattern of blood procurement, ordering and utilization in a university hospital in eastern Saudi Arabia. Saudi Med J 2002;23:555-61. (Pubitemid 34624927)
123. Saxena AK, Panhotra BR, Naguib M, Uzzaman W, Al MK. Nosocomial transmission of syphilis during haemodialysis in a developing country. Scand J Infect Dis 2002;34:88-92. (Pubitemid 34213367)
124. Hashemi FB, Pourakbari B, Yazdi JZ. Frequency of Chlamydia trachomatis in women with cervicitis in Tehran, Iran. Infect Dis Obstet Gynecol 2007:2007;67014.
125. Ghanaat J, Sadeghian A, Ghazvini K, Nassiri MR. Prevalence and risk factors for hepatitis B virus infections among STD patients in northeast region of Iran. Med Sci Monit 2003;9:CR91-4. (Pubitemid 36335761)
126. Zirak-Zadah T, Delavarian H, BahavarMA,Majidi V, Yaminifar R, Masoumi P. Penicillin-resistant strains of Neisseria gonorrhoeae in Shahre-Now. Trop Doct 1977;7:57-8. (Pubitemid 8048313)
127. Ghazal-Aswad S, Badrinath P, Osman NA, Abdul-Khalik S, Raasclou T. Is there a correlation between vaginal Chlamydia infection and cervical smear abnormalities? A community-based study in the Al-Ain district, United Arab Emirates. J Obstet Gynaecol Res 2006;32:63-7.
128. Ghazal-Aswad S, Badrinath P, Osman N, Abdul-Khaliq S, Mc Ilvenny S, Sidky I. Prevalence of Chlamydia trachomatis infection among women in a Middle Eastern community. BMC Womens Health 2004;4:3.
129. Ortayli N, Sahip Y, Amca B, Say L, Sahip N, Aydin D. Curable sexually transmitted infections among the clientele of a family planning clinic in Istanbul, Turkey. Sex Transm Dis 2001;28:58-61. (Pubitemid 32064212)
130. Ozdag D, Us D, Demirezen S, Beksac S. Investigation of Chlamydia trachomatis positivity in women with and without gynecologic complaints by cytologic and direct immunofluorescence methods [in Turkish]. Mikrobiyol Bul 2007; 41:51-61.
131. Agacfidan A, Moncada J, Aydin D, Onel M, Alp T, Isik N, et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in Turkey among men with urethritis. Sex Transm Dis 2001;28:630-2. (Pubitemid 33055106)
132. Dolapci I, Tekeli A, Ozsan M, Yaman O, Ergin S, Elhan A. Detecting of Mycoplasma genitalium in male patients with urethritis symptoms in Turkey by polymerase chain reaction. Saudi Med J 2005;26:64-8. (Pubitemid 40372502)
133. Sirmatel F, Sahin N, Sirmatel O, Telli E, Kececi S. Chlamydia trachomatis antigen positivity in women in risk groups and its relationship with the use of antibiotics. Jpn J Infect Dis 2005;58:41-3. (Pubitemid 40425373)
134. Ozturk CE, Ozdemir I, Yavuz T, Kaya D, Behcet M. Etiologic agents of cervicovaginitis in Turkish women. Saudi Med J 2006;27:1503-7. (Pubitemid 351833159)
135. Aydin F, Cubukcu K, Yetiskul S, Yazici Y, Kaklikkaya N. Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital [in Turkish]. Mikrobiyol Bul 2002;36:85-90.
136. Kocak N, Hepgul S, Ozbayburtlu S, Altunay H, Ozsoy MF, Kosan E, et al. Trends in major transfusion-transmissible infections among blood donors over 17 years in Istanbul, Turkey. J Int Med Res 2004;32:671-5. (Pubitemid 39567267)
137. Mutlu B, Meric M, Willke A. Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors [in Turkish]. Mikrobiyol Bul 2004;38:445-8.
138. Gdoura R, KchaouW, Ammar-Keskes L, Chakroun N, Sallemi A, Znazen A, et al. Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl 2008;29:198-206. (Pubitemid 351345717)
139. Gdoura R, Keskes-Ammar L, Bouzid F, Eb F, Hammami A, Orfila J. Chlamydia trachomatis and male infertility in Tunisia. Eur J Contracept Reprod Health Care 2001;6:102-7. (Pubitemid 32735341)
140. Ben Hamida A, Kechrid A, Saadallah N, Chihi B, Kamoun R, Gueddana N. Incidence and management of male urethritis in the district of Tunis [in French]. Rev Epidemiol Sante Publique 1999;47:397-402. (Pubitemid 29526558)
141. Sellami A, Kharfi M, Youssef S, Zghal M, Fazaa B, Mokhtar I, et al. Epidemiologic profile of sexually transmitted diseases (STD) through a specialized consultation of STD [in French]. Tunis Med 2003;81:162-6. (Pubitemid 38500274)
142. Znazen A, Trigui B, Zghal-Trigui Y, Gdoura R, Zouari N, Hammami A. Male gonococcal urethritis in the region of Sfax (1996-2000) [in French]. Tunis Med 2003;81: 329-33. (Pubitemid 36966315)